Results for “two-shot penalty”

Women with higher blood levels of two common per- and polyfluoroalkyl substances, also familiarly known as PFAS, were more likely to develop estrogen receptor-negative, or ER-negative, breast cancer, according to a new study by the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (HHS). PFAS are a large group of chemicals used in common consumer products. Often referred to as "forever chemicals," PFAS do not break down easily in the environment and can remain in the body for years.

The companies are part of a system intended to protect patients from surprise medical bills.

CVS Health says it is splitting in two, putting its retail pharmacy in one unit and its insurance side, which oversees Aetna and Caremark, will be separate. The CEO says the idea is to help customer engagement, affordability and care coordination.

A study by MELISA Institute, published in Scientific Reports, shows how researchers can track thousands of proteins in cervicovaginal fluid over seven consecutive days. By analyzing samples collected daily from the same women, the team could compare how well two workflows detected changes in protein abundance.

A University of Cambridge team has had a third success with its AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health. Its new broad-spectrum bird flu vaccine gave complete protection against globally circulating, diverse variants of the disease in animal trials.

A research team led by Dr. Sheng Nengyin of the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has reframed ZC4H2-associated rare disorder (ZARD)—a disorder marked by intellectual disability, developmental delays, muscle weakness and other neurological or physical abnormalities—as a "disease spectrum" rather than a condition driven by a single mechanism.

A study in Norway has identified a link between a mother's vitamin A levels and her baby's birth weight. The study shows that over 43% of the women had low vitamin A levels during the latter part of their pregnancy. While almost no one had levels classified as a severe vitamin A deficiency, two out of five had insufficient levels. The study examined 723 women who experienced entirely normal pregnancies.

Two Tulane University sophomores told Fox News Digital about how they found a previously unknown muscle in the hip during a cadaver lab session that even their professor couldn't identify.

As low-cost and straightforward an intervention as automated text messaging could make a significant contribution to tackling London's below-average bowel cancer screening rates, according to a study led by the University of Surrey. The project compared two approaches to encourage people who didn't respond to their initial invitation to complete their cancer screening.

Two-thirds of Australian pediatricians don't know where to refer adolescents for support to quit vaping, new Federation University research has found—highlighting a critical gap in the response to youth vaping.

Acute myeloid leukemia (AML) is an aggressive blood cancer in which abnormal, immature cells build up in the bone marrow, disrupting the production of healthy blood cells. Now, a new study, led by Dr. José Luis Sardina's group at the Josep Carreras Leukaemia Research Institute (IJC), examines how two systems that help control normal blood cell development are connected: the chemical marks on DNA and the regulation of RNA, which carries instructions for making proteins. The work is published in the journal Science Advances.

The World Health Organization on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.

Massachusetts voters decisively shot down a ballot initiative that would have dismantled the state’s recreational cannabis industry.

Rice University's Han Xiao has used his AI-supported Sequence Display technology to expand the targeting abilities of CRISPR/Cas9. In a paper recently published in Nature Communications, Xiao evolved several variants of a compact Cas9 that could efficiently target stretches of DNA previously inaccessible for editing. The research included a proof-of-concept study in which the evolved Cas9s were successfully used to edit two genes found in coronary heart disease.

Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.

The Democratic flip of the Senate is expected to put two Democrats who support Medicare for All in charge of key committees.

Two distinct patterns of molecules in the blood linked to an ultra-processed diet and a minimally processed diet have been identified in a new study by UCL (University College London) and Imperial College London researchers.

A cryptic email sent to Mass General Brigham employees by the health system's CEO is stirring staff anxiety less than two weeks after a round of layoffs.

A study led by the Cell Cycle and Cancer Group at the Vall d'Hebron Institute of Oncology (VHIO) has identified a vulnerability in liver cancer that could guide the development of new therapies. The work, published in Proceedings of the National Academy of Sciences, shows that some tumor cells depend on the combined action of two proteins, CDK16 and CDK18, to repair their DNA and continue multiplying. When both are inactivated, damage accumulates and the cells' ability to survive is impaired.

The FDA gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention medicine

Our brain's wiring is shaped both by genes and what we experience, and the visual system is a great model for studying how the two work together. Before the eyes ever open, genetic programs lay down a first draft of the brain's visual circuits. But once they open, experience takes over, with visual information refining the initial draft.

The U.S. Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.

Two studies involving investigators at Cedars-Sinai Guerin Children's and the University of Cambridge, U.K., highlight the growing potential of whole-genome sequencing to transform the diagnosis and treatment of childhood conditions such as cerebral palsy and cancer.

The FDA has approved a generic HIV prevention shot, a key step in widening access for dozens of lower-income countries.

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium nodules—rotational atherectomy and intravascular lithotripsy (IVL)—before coronary stent placement allowed stents to expand more fully than IVL alone in patients with calcified coronary nodules.

After nearly two decades of decline, valvular heart disease death rates have increased from 2018 to 2023 and are predicted to remain elevated through 2040, according to independent, new preliminary research presented at the American Heart Association's Scientific Sessions 2026, held Nov. 6–9 in Chicago.

Two women from Wales are among the growing number of people having lip filler after cleft lip and palate surgery.

It's been just over two years since the rise of Make America Healthy Again, or MAHA. How well is the Trump administration meeting its promises?

No matter what happens on Election Day, the midterms will have sweeping implications for American health care. More than two dozen experts on what could come next.

Studies conducted in various countries indicate that approximately 60% of people over age 65 currently live with two or more chronic conditions. With the aim of reversing this trend and promoting healthy aging, European researchers have created a new personalized indicator that provides a detailed snapshot of a patient's metabolism by analyzing, with high precision, the chemicals the body produces to function.

A Stanford Medicine study identified an often-overlooked period of vulnerability for cancer survivors: Mental health disorders identified two to five years after a cancer diagnosis were associated with a 119% higher rate of death from cancer compared with patients without documented mental disorders during the same period.

An uninsured woman sought help at a Virginia urgent care center after being stung by a wasp. She said she was stunned when the center asked her to pay before giving her a shot to reverse her allergic reaction.

More than 50,000 people in Europe died this summer from heat, a record high amount, a new study finds

The agency replied two months later, saying it had “competing priorities,” officials from a coalition of Western states said.

Ebola disease from the fast-moving outbreak in Congo has now spread to four other countries, including two where it’s active

Two-year-old conjoined twin sisters saw each other face-to-face for the first time after a successful 24-hour surgery to separate them. Ian Lee reports from the children's hospital in St. Louis, where it happened.

Before actor Eric Dane died after a two-year battle with ALS in Feb. 2026, he shared details about life with ALS and how the illness progressed.

This is a MedPage Today story. A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total of up to $100 million to settle Justice Department allegations of fraudulent billing for health conditions that were exaggerated or didn't exist. Independent Health Association of Buffalo, which operates two Medicare Advantage plans, will pay up to $98 million. Betsy Gaffney, CEO of medical records review company DxID, will pay $2 million, according to the settlement agreement. Neither admitted wrongdoing. "Today's result sends a clear message to the Medicare Advantage community that the United States will take appropriate action against those who knowingly submit inflated claims for reimbursement," Michael Granston, a Department of Justice (DOJ) deputy assistant attorney general, said in announcing the settlement on December 20. Frank Sava, a spokesperson for Independent Health, said in a statement: "The assertions by the DOJ...